Showing results (101-110 of 116) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|February 22, 2012
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinibFrancesco Grossi, Erika Rijavec, Maria Giovanna Dal Bello, et al.Oncology Reports|September 3, 2009
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective studyLaura Boldrini, Greta Alì, Silvia Gisfredi, et al.In Vivo (Athens, Greece)|July 2, 2020
Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian CenterPinuccia Faviana, Laura Boldrini, Barbara Musco, et al.Oncology Reports|January 14, 2004
Regulation of telomerase and its hTERT messenger in colorectal cancerLaura Boldrini, Pinuccia Faviana, Silvia Gisfredi, et al.Journal of Experimental & Clinical Cancer Research : CR|October 11, 2014
EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definitionVirginia Rotella, Lorenzo Fornaro, Enrico Vasile, et al.Gynecologic Oncology|February 9, 2025
Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort studyCarmine Valenza, Marta Mongillo, Maria Vittoria Visconti, et al.Genes & Cancer|April 25, 2017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell linesOmbretta Melaiu, Calogerina Catalano, Chiara De Santi, et al.Oncology Reports|July 5, 2016
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single centerRiccardo Giannini, Cristiana Lupi, Elisa Sensi, et al.The Oncologist|November 28, 2024
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort studyCarmine Valenza, Eleonora Nicolò, Marta Mongillo, et al.European Journal of Cancer (Oxford, England : 1990)|June 23, 2024
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trialsEleonora Nicolò, Sara Gandini, Federica Giugliano, et al.Pageof 12